Samsung Epis sets up 1st overseas bio R&D center in Beijing
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-05-29 15:15 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Property, Asia, China, Drugs, World News, Asia Pacific
--------------------------------------------------------------------
Snippet:
Samsung Epis Holdings, the holding company of biosimilar drug developer Samsung Bioepis, said Friday it has established a research and development center in China as part of efforts to strengthen its new drug development capabilities.
--------------------------------------------------------------------